Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
Incyte Corporation
Incyte Corporation
Massive Bio, Inc.
Incyte Corporation
Cogent Biosciences, Inc.
Advice Pharma Group srl
Pfizer
Prelude Therapeutics
Takeda
Notable Labs
Incyte Corporation
Medigene AG
Kiadis Pharma
LEO Pharma
Incyte Corporation
Traws Pharma, Inc.
Polyphor Ltd.
Sanofi
Ariad Pharmaceuticals
INSYS Therapeutics Inc
Alaunos Therapeutics
Novartis